Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akeso, Biomarin, Boehringer Ingelheim, Bristol Myers Squibb, Cansino, Kancera, Glenmark, J&J, Merck & Co., Regeneron, Scopus, Verastem.